Enovis (ENOV) Long-Term Deferred Tax (2010 - 2011)
Enovis' (ENOV) quarterly Long-Term Deferred Tax came in at $44.0 million in Q4 2011, down 16.03% year-over-year from $52.4 million in Q4 2010, and down 8.41% quarter-over-quarter from $48.0 million in Q3 2011.
Powered by 
Analysis
Enovis (ENOV) Long-Term Deferred Tax (2010 - 2011) Analysis & Trends
Enovis (ENOV) has reported Long-Term Deferred Tax for 2 consecutive years, with $44.0 million the latest figure, recorded in Q4 2011.
- On a quarterly basis, Long-Term Deferred Tax fell 16.03% year-over-year to $44.0 million in Q4 2011; TTM through Dec 2011 was $44.0 million, a 16.03% decrease from a year earlier, with the FY2011 full-year figure at $44.0 million, down 16.03% from the prior year.
- Long-Term Deferred Tax was $44.0 million for Q4 2011 at Enovis, down from $48.0 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $52.4 million in Q4 2010 and troughed at $44.0 million in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Enovis | 1.08 Bn | 1.06 Bn | 359.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 43.99 Mn |
| Sep 30, 2011 | 48.03 Mn |
| Jul 1, 2011 | 52.12 Mn |
| Dec 31, 2010 | 52.39 Mn |